BN-201

DB18295InvestigationalSmall molecule

BN-201: Overview.

Chemical structure of BN-201
Formula / weight
C25H38FN5O4 · 491.608 g/mol (avg)
Also known as
Glycinamide, n-(2-(2-fluorophenyl)ethyl)glycyl-n-(2-methylpropyl)glycyl-n2-(3-(2-oxo-1-pyrrolidinyl)propyl)- · N-(2-amino-2-oxoethyl)-2-(2-((4-fluorophenethyl)amino)-N-isobutylacetamido)-N-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide N-({Carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)propyl}-carbamoyl}-methyl)-2-[2-(2-fluorophenyl)-ethylamino]-N-isobutyl-acetamide
Code names
BN-201 · G-79

Resolves to

Compound
UNIIKCN37L7EIHCAS1361200-34-1
Structure
InChIKeyODCKWAPNRBCXHV-UHFFFAOYSA-NSMILESCC(C)CN(CC(=O)N(CCCN1CCCC1=O)CC(N)=O)C(=O)CNCCC1=CC=CC=C1F

What you can answer from here — as of September 17, 2023

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of BN-201, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In